-
公开(公告)号：KR1020160059028A
公开(公告)日：2016-05-26
申请号：KR1020140159911
申请日：2014-11-17
Applicant: 한국식품연구원
CPC classification number: A61K31/7048 , A23L33/10 , A23V2002/00 , A23V2200/00 , A61K9/0095 , A61K9/16 , A61K9/20 , A61K9/48
Abstract: 본발명은푸니칼라진(punicalagin)을유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품에관한것으로, 본발명에따른푸니칼라진은전립선무게감소효과가우수하므로, 이를유효성분으로함유하는전립선비대증의예방또는치료용약학적조성물, 식품조성물및 건강기능식품으로사용할수 있다.
Abstract translation: 本发明涉及一种用于预防或治疗良性前列腺增生的药物组合物，其包含作为活性成分的肾上腺素作为食物组合物，以及健康功能性食品。 根据本发明，防腐剂对减轻前列腺的重量具有优异的效果，可以用作预防或治疗良性前列腺增生的药物组合物，其包含与活性成分相同的食品组合物，和 健康功能食品。
-
公开(公告)号：KR101614144B1
公开(公告)日：2016-05-02
申请号：KR1020140165273
申请日：2014-11-25
Applicant: 한국식품연구원
IPC: A61K31/4525 , A61K31/36 , A61P11/02
CPC classification number: A61K31/4525 , A61K31/357 , A61K31/36 , A61K31/435
Abstract: 본발명은피페린또는이의염을유효성분으로후각과민증의예방및 치료용약학적조성물에관한것이다. 또한, 본발명은피페린또는이의염을유효성분으로함유하는후각과민증의예방및 완화를위한건강기능식품에관한것이다. 본발명의조성물은후각신호전달을억제함으로써후각과민증을억제하는우수한효과가있다.
Abstract translation: 本发明涉及一种用于预防和治疗高血糖的药物组合物，其包含胡椒碱或其盐作为活性成分。 此外，本发明涉及一种用于预防和缓解高血糖的健康功能性食品，其包含胡椒碱或其盐作为活性成分。 通过抑制嗅觉信号的输送，本发明的组合物具有优异的抑制高血压的效果。
-
公开(公告)号：KR1020150145820A
公开(公告)日：2015-12-31
申请号：KR1020140075016
申请日：2014-06-19
Applicant: 한국식품연구원
IPC: A61K36/896 , A61P11/02 , A61P11/00
Abstract: 본발명은둥글레추출물을유효성분으로함유하는후각과민증예방또는치료용약학조성물에관한것이다. 또한, 본발명은둥글레추출물을유효성분으로함유하는후각과민증예방또는개선용건강기능식품에관한것이다. 또한, 본발명은둥글레추출물을함유하는악취억제용방향제조성물에관한것이다. 본발명의옥죽을함유하는조성물은후각자극에의한 cAMP의생성을억제내지감소시켜다양한후각자극물질에대해뇌에서냄새인지를못하게하는역할을한다.
Abstract translation: 本发明涉及一种药物组合物，其包含作为预防或治疗高血糖症的活性成分的金atum提取物。 此外，本发明涉及一种保健功能食品，其包含atum atum提取物作为预防或缓解高血症的活性成分。 此外，本发明涉及一种空气清新剂组合物，其包含用于抑制恶臭的金缕梅提取物。 通过抑制或减少由嗅觉刺激引起的cAMP产生，本发明的包含藿香的组合物在通过抑制或减少cAMP产生方面起到防止嗅觉刺激的各种物质对脑中的气味识别的作用。
-
-
65.发明授权
公开(公告)号：KR101536232B1
公开(公告)日：2015-07-15
申请号：KR1020120158100
申请日：2012-12-31
Applicant: 한국식품연구원
Abstract: 본발명은산씀바귀() 추출물을유효성분으로포함하는 TRPV1(Transient Receptor Potential channel, Vanilloid subfamily member 1)-매개질환의예방, 치료또는개선용조성물에관한것이다. 본발명의조성물은천연식물재료인산씀바귀로부터추출한조성물로써인체에부작용이없는조성물이고, 상기조성물은통증및 염증의예방, 치료또는개선효과를제공한다.
-
Patent Agency Ranking
公开(公告)号：KR1020140006376A
公开(公告)日：2014-01-16
申请号：KR1020120073081
申请日：2012-07-04
Applicant: 한국식품연구원
IPC: A61K31/404 , A61K31/4025 , A61P35/00 , A61P25/28
CPC classification number: A61K31/404 , A23L29/045 , A61K9/0095 , A61K9/08 , A61K9/10 , A61K9/14 , A61K9/20 , A61K9/48 , Y10S514/886
Abstract: The present invention relates to a pharmaceutical composition containing 3,3'-Diindolymethane as an active ingredient for preventing and treating inflammatory diseases and angiogenesis inhibitory activity. According to the present invention, the 3,3'-Diindolymethane has an excellent effect in inhibiting angiogenesis and inflammation, thereby being used as the active ingredient in the pharmaceutical composition and health functional food for preventing and treating inflammatory diseases. [Reference numerals] (AA,EE,II,MM) Normal group; (BB,FF,JJ,NN) Control group; (CC,GG,KK,OO) Experimental group 1; (DD,HH,LL,PP) Experimental group 2
Abstract translation: 本发明涉及含有3,3'-二取代甲烷作为预防和治疗炎性疾病和血管生成抑制活性的活性成分的药物组合物。 根据本发明，3,3'-二聚甲烷在抑制血管发生和炎症中具有优异的效果，因此用作用于预防和治疗炎性疾病的药物组合物和保健功能食品中的活性成分。 （标号）（AA，EE，II，MM）正常组; （BB，FF，JJ，NN）对照组; （CC，GG，KK，OO）实验组1; （DD，HH，LL，PP）实验组2
-
公开(公告)号：KR101327938B1
公开(公告)日：2013-11-14
申请号：KR1020110037694
申请日：2011-04-22
Applicant: 한국식품연구원
IPC: A61K31/215 , A61K31/21 , A61K9/48 , A61P3/04
Abstract: 본 발명은 메틸 카페이트를 유효성분으로 함유하는 비만 및 지질 관련 대사성 질환의 예방 및 치료용 약학적 조성물과 건강기능식품에 관한 것이다. 상기 조성물 또는 건강기능식품은 지방세포분화 저해 효능이 우수하다.
-
公开(公告)号：KR1020130098759A
公开(公告)日：2013-09-05
申请号：KR1020120020537
申请日：2012-02-28
Applicant: 한국식품연구원
CPC classification number: Y02A90/26
Abstract: PURPOSE: A method for diagnosing aging is provided to diagnose aging and related diseases by measuring a change in the concentration of a specific metabolite in a liver extract and to treat aging-related diseases. CONSTITUTION: A method for diagnosing aging comprises the steps of: measuring the concentration of one selected among a metabolite group including 3-methylglutarylcarnitine, isovalerylcarnitine, palmitoylcarnitine, iobutyrylcarnitine, hypoxanthine, patothenic acid, lysophosphatidylcholine(C18:0) and lysophosphatidylcholine(C22:6); measuring the concentration of one selected among the metabolite group; and determining aging when the primarily measured concentration is higher than the secondarily measured concentration.
Abstract translation: 目的：通过测量肝脏提取物中特定代谢物浓度的变化和治疗老化相关疾病，提供诊断衰老的方法诊断衰老及相关疾病。 构成：用于诊断老化的方法包括以下步骤：测量选自包括3-甲基戊二酰肉碱，异戊基肉毒碱，棕榈酰肉碱，异丁酸肉碱，次黄嘌呤，氨基苯甲酸，溶血磷脂酰胆碱（C18：0）和溶血磷脂酰胆碱（C22：6） ）; 测定代谢组中选出的1种浓度; 并且当主要测量的浓度高于二次测量的浓度时，确定老化。
-
69.发明公开
公开(公告)号：KR1020120061018A
公开(公告)日：2012-06-12
申请号：KR1020100109058
申请日：2010-11-04
Applicant: 한국식품연구원
Abstract: PURPOSE: A pharmaceutical composition and health functional food containing p-xyleneselenocyanate are provided to prevent and treat obesity and lipid-related metabolic disorders. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic disorders contains 0.1-50 wt% of p-xylene selenocyanate as an active ingreedient. The metabolic diseases include diabetes, hyperlipidemia, fatty liver, artheriosclerosis, hypertension, cardiovascular diseases, or a combination thereof. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, oral formulation of aerosol, external use formulation, suppository, or sterilized injection solution. A health functional food for preventing and relieving obesity and lipid-related metabolic disorders contains p-xylene selenocyanate as an active ingredient.
Abstract translation: 目的：提供含有对二甲苯硒异氰酸酯的药物组合物和保健功能食品，用于预防和治疗肥胖症和与脂质有关的代谢紊乱。 构成：用于预防和治疗肥胖症和与脂质有关的代谢紊乱的药物组合物含有0.1-50重量％的对二甲苯硒氰酸酯作为活性成分。 代谢疾病包括糖尿病，高脂血症，脂肪肝，神经硬化，高血压，心血管疾病或其组合。 组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，气雾剂口服制剂，外用制剂，栓剂或灭菌注射液的形式制造。 用于预防和减轻肥胖症和与脂质有关的代谢紊乱的健康功能食品含有对二甲苯硒氰酸酯作为活性成分。
-
公开(公告)号：KR1020120061016A
公开(公告)日：2012-06-12
申请号：KR1020100109049
申请日：2010-11-04
Applicant: 한국식품연구원
Abstract: PURPOSE: A pharmaceutical composition containing sulforaphane is provided to suppress adipocyte differentiation and to prevent and treat obesity and metabolic diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid metabolic diseased contains 0.1-50 wt% of sulforaphane as an active ingredient. The sulforaphane includes R,S-sulforaphane, R-sulforaphane, or S-sulforaphane. The composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, aerosol, suppository, or sterilization injection solution. A health functional food for preventing and relieving obesity and lipid metabolic diseases contains sulforaphane as an active ingredient.
Abstract translation: 目的：提供含有萝卜硫素的药物组合物，以抑制脂肪细胞分化，预防和治疗肥胖症和代谢疾病。 构成：用于预防和治疗肥胖症和脂质代谢疾病的药物组合物含有0.1-50重量％的萝卜硫素作为活性成分。 萝卜硫烷包括R，S-四氢萘烷，R-萝卜硫烷或S-萝卜硫烷。 该组合物以粉末，颗粒，片剂，胶囊，悬浮液，乳剂，糖浆，气雾剂，栓剂或灭菌注射溶液的形式制备。 用于预防和减轻肥胖和脂质代谢疾病的健康功能食品含有萝卜硫素作为活性成分。
-
-
-
-
-
-
-
-
-
Search Results
72
records
(took 0.028 seconds)
